ArticleJournal of clinical laboratory analysis2017
The establishment of biological reference intervals of nontraditional glycemic markers in a Chinese population.
Article in Journal of clinical laboratory analysis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 24 citations in OpenAlex.
- Reference Interval for Glycated Albumin, 1,5-AG/GA, and GA/HbA1c Ratios and Cut-Off Values for Type 1, Type 2, and Gestational Diabetes: A Cross-Sectional Study.Biomedicines · 2024Article
- Clinical evaluation of the reference intervals for diabetes in Chinese geriatric population: a cross-sectional cohort study protocol.BMJ open · 2024Article
- Postnatal levels of glycated albumin and glycated hemoglobin A1c in mothers of large-for-gestational-age newborns.Frontiers in pediatrics · 2024Article
- Prepregnancy body mass index and glycated albumin in the third trimester may predict infant complications in gestational diabetes mellitus: a retrospective cohort study.Diabetology international · 2023Article
- Analytical Challenges in Diabetes Management: Towards Glycated Albumin Point-of-Care Detection.Biosensors · 2022Review
- Using Glycated Albumin and Stimulated C-Peptide to Define Partial Remission in Type 1 Diabetes.Frontiers in endocrinology · 2022Article
- Glycated albumin as a biomarker for diagnosis of diabetes mellitus: A systematic review and meta-analysis.World journal of clinical cases · 2021Article
- Factors associated with glycated albumin in adults without diabetes.Medicine and pharmacy reports · 2021Article
- Association between a biomarker of glucose spikes, 1,5-anhydroglucitol, and cancer mortality.BMJ open diabetes research & care · 2020Article
- Glycated albumin in pregnancy: reference intervals establishment and its predictive value in adverse pregnancy outcomes.BMC pregnancy and childbirth · 2020Article
- Establishing a blood fructosamine reference range for the Brazilian population based on data from ELSA - Brasil.Practical laboratory medicine · 2019Article
- Data for serum 1,5 anhydroglucitol concentration in different populations.Data in brief · 2018Article
- Establishment of Community-Based Reference Intervals for Fructosamine, Glycated Albumin, and 1,5-Anhydroglucitol.Clinical chemistry · 2018Article
- Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe established the reference intervals for glycated albumin (GA), fructosamine (FA), and 1,5-anhydroglucitol (1,5-AG) in a Chinese healthy population.
methodsThis study enrolled a total of 458 eligible reference individuals, consisted of 226 men and 232 women, aged from 20~79 years (median age 43 years), who attending routine healthy checks. We stratified the subjects according to gender (males and females) and age (20-39, 40-59, and 60-79 years), and combined statistical methods with Lahti algorithm, as well as appropriate clinical consideration, to judge whether partitioning for data was needed.
resultsGlycated albumin levels between males and females were statistically different (P<.001), but the absolute difference between the upper reference limits was only 0.31%, which was too small to be clinically relevant. GA levels across the three age groups were statistically different (P<.001), and Lahti algorithm suggested partitioning for 20-59 and 60-79 years, which reference intervals were 10.38%-13.89% and 10.23%-14.79%, respectively. 1,5-AG levels in males were significant higher than females (P<.001), and absolute difference was 51 μmol/L (8.5 μg/mL) in mean level. Thus, partitioning for gender was needed. Reference intervals for 1,5-AG were 107-367 μmol/L for males and 79-306 μmol/L for females. The absolute difference of the lower reference limits for FA was only 7 μmol/L between males and females. FA levels across the three age groups were not statistically different (P>.05). The reference interval for FA was 220-298 μmol/L.
conclusionNew reference intervals for nontraditional glycemic markers were established based on a Chinese population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.